Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
46,376,919
-
Shares change
-
+45,822
-
Total reported value, excl. options
-
$667,832,541
-
Value change
-
-$2,739,089
-
Put/Call ratio
-
68%
-
Number of buys
-
42
-
Number of sells
-
-34
-
Price
-
$14.40
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2018
99 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2018.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,376,919 shares
.
Largest 10 shareholders include NEA Management Company, LLC (9,089,041 shares), WELLINGTON MANAGEMENT GROUP LLP (5,673,374 shares), OppenheimerFunds, Inc. (4,422,132 shares), FMR LLC (3,801,483 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,443,579 shares), BlackRock Inc. (2,853,504 shares), Redmile Group, LLC (2,048,147 shares), FRANKLIN RESOURCES INC (2,016,325 shares), STATE STREET CORP (1,756,353 shares), and Vanguard Group Inc (1,691,550 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.